Page 2 - Sanket Koul

Respiratory drug sales rise 17.7% in April on seasonal flu, asthma rise

Respiratory drug sales outpaced overall pharmaceutical market growth in April, driven by seasonal flu, pollution, and rising asthma and COPD cases

Generic GLP-1 sales increase, but innovators retain market share

Over 25 versions of weight-loss drugs currently available in the market

Health Ministry activates precautionary surveillance amid hantavirus

The Health Ministry has stepped up surveillance after probable hantavirus cases were reported onboard the cruise ship MV Hondius, with two Indians under observation

NeoLiv's Faridabad plotted project clocks ₹1,251 crore sales in hours

NeoLiv said its luxury plotted township project in Faridabad was sold out within six hours of launch, driven by HNIs, NRIs and investors

DRL-Nestle JV launches Celevida product line for GLP-1 therapy patients

Dr Reddy's-Nestle Health Science JV launched Celevida GLP+ to support nutrition and muscle health among patients on GLP-1 and GIP therapies

India's pharma market grows 10.3% in April on strong chronic performance

India's pharmaceutical market grew 10.3 per cent in April, led by strong demand for anti-diabetes, cardiac and respiratory therapies

Alpha Corp to invest ₹750 cr in EIL's stressed assets after SC nod

Alpha Corp to revive EIL's stalled projects with ₹750 crore investment after Supreme Court clears resolution plans, offering relief to over 3,000 buyers

West Bengal set to get PMJAY cover after BJP's election victory

West Bengal likely to re-enter PMJAY, expanding health cover and paving the way for Centre-state scheme convergence

Centre removes hospital height cap, eases norms for vertical expansion

New NBCS 2026 norms remove 45-metre cap on hospital buildings, enabling vertical expansion, lowering capex and reducing reliance on greenfield projects, say industry executives

Centre eases CME norms for medtech firms under UCMPMD with conditions

New UCMPMD amendment allows overseas training without prior approval in cases where equipment or expertise is unavailable domestically, shifting compliance responsibility to firms

Smartworks targets up to 30% growth in operational area in FY27

Co-working firm expects expansion from 10.1 msf base, supported by strong office absorption, rising demand for managed workspaces, and visibility of future supply

Dr Lal PathLabs Q4FY26 results: Net profit falls 15%; revenue rises 16.6%

Diagnostics firm reports profit decline due to prior-year tax benefit, while revenue growth remains strong on higher sample volumes and improved test mix

Eli Lilly backs Haryana FDA action on counterfeit Mounjaro seizures

Pharma major says seized fake Mounjaro in Gurugram did not originate from its supply chain, urges vigilance and purchase only through authorised channels

Dubai removes real estate investment limit for two-year investor visa

Experts laud timing of Dubai's move to ease investor visa norms, which could revive interest among Indian buyers amid recent geopolitical uncertainty

Canada approves DRL's Ozempic generic after months of regulatory logjam

DRL is the first company to receive market authorisation for a generic semaglutide injection in Canada. It is the first generic semaglutide to be approved in a G7 country

Anant Raj to enter Singapore data centre market with new subsidiary

The Delhi-based developer plans to set up a wholly owned subsidiary in Singapore to offer data centre and cloud services, marking its first overseas expansion amid rising demand

Centre sets eyes on heatwave management as higher temperatures grip India

Labour Ministry calls for urgent heatwave protection measures for workers

IHH-Daiichi case: Tokyo court concludes hearing, ruling on September 10

The deal was held up in court amid Daiichi Sankyo's long-running dispute with the Singh brothers over its purchase of Ranbaxy Laboratories more than a decade ago

West Asia crisis: Affordable housing may lose more ground amid rising costs

Rising input costs amid West Asia tensions may shrink affordable housing supply, as thin margins deter developers despite strong demand in urban India

Medtech backs India-NZ FTA, flags CDSCO exclusion as key regulatory gap

Medical device makers welcome India-NZ FTA for easing market access and exports, but flag absence of CDSCO in regulatory recognition framework as a key gap